Sökning: WFRF:(Mohammad Moman A) >
Intravenous beta-bl...
-
Mohammad, Moman A.Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular Cardiology,Lund University Research Groups,Skåne University Hospital
(författare)
Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality : a Swedish nationwide observational study
- Artikel/kapitelEngelska2017
Förlag, utgivningsår, omfång ...
-
Europa Edition,2017
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:oru-59137
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-59137URI
-
https://doi.org/10.4244/EIJ-D-16-01021DOI
-
https://lup.lub.lu.se/record/f86577e5-8c64-4f47-b639-bbcca135544bURI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:136165422URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Funding Agencies:SSF (TOTAL-AMI) Knut and Alice Wallenbergs Foundation ALF Skåne University Hospital
-
Aims: Our aim was to investigate the impact of intravenous (IV) beta-blocker therapy on short-term mortality and other in-hospital events in patients with ST-segment elevation myocardial infarction (STEMI) treated with dual antiplatelet therapy (DAPT) and primary percutaneous coronary intervention (PCI).Methods and results: Using the nationwide Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) registry, we identified all patients with STEMI undergoing PCI between 2006 and 2013. Patients with cardiogenic shock and cardiac arrest at presentation were excluded. The primary endpoint was mortality within 30 days. Secondary endpoints were in-hospital events (mortality, cardiogenic shock and left ventricular ejection fraction [LVEF] <40% at discharge). We adjusted for confounders with a multivariable model and propensity score matching. Out of 16,909 patients, 2,876 (17.0%) were treated with an IV beta-blocker. After adjusting for confounders, the IV beta-blocker group had higher 30-day all-cause mortality (HR: 1.44, 95% CI: 1.14-1.83), more in-hospital cardiogenic shock (OR: 1.53, 95% CI: 1.09-2.16) and were more often discharged with an LVEF <40% (OR: 1.70, 95% CI: 1.51-1.92).Conclusions: In this large nationwide observational study, the use of IV beta-blockers in patients with STEMI treated with primary PCI was associated with higher short-term mortality, lower LVEF at discharge, as well as a higher risk of in-hospital cardiogenic shock.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Andell, PontusLund University,Lunds universitet,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Molecular Cardiology,Lund University Research Groups,Skåne University Hospital(Swepub:lu)med-poa
(författare)
-
Koul, SashaLund University,Lunds universitet,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Molecular Cardiology,Lund University Research Groups,Skåne University Hospital(Swepub:lu)med-sku
(författare)
-
Desta, LiyewKarolinska Institutet
(författare)
-
Jernberg, TomasKarolinska Institutet,Karolinska Institute
(författare)
-
Omerovic, ElmirDepartment of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden
(författare)
-
Spaak, JonasKarolinska Institutet
(författare)
-
Fröbert, Ole,1964-Örebro University,Region Örebro län,Örebro universitet, Institutionen för medicinska vetenskaper,Department of Cardiology, Örebro University Hospital, Örebro, Sweden(Swepub:oru)oft
(författare)
-
Jensen, JensKarolinska Institutet,Karolinska Institute
(författare)
-
Engstrøm, ThomasThe Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark(Swepub:lu)th4331en
(författare)
-
Hofman-Bang, ClaesDepartment of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden
(författare)
-
Persson, HansKarolinska Institutet
(författare)
-
Erlinge, DavidLund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular Cardiology,Lund University Research Groups,Skåne University Hospital(Swepub:lu)kard-der
(författare)
-
KardiologiSektion II
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:EuroIntervention: Europa Edition13:2, s. E210-E2181774-024X1969-6213
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Mohammad, Moman ...
-
Andell, Pontus
-
Koul, Sasha
-
Desta, Liyew
-
Jernberg, Tomas
-
Omerovic, Elmir
-
visa fler...
-
Spaak, Jonas
-
Fröbert, Ole, 19 ...
-
Jensen, Jens
-
Engstrøm, Thomas
-
Hofman-Bang, Cla ...
-
Persson, Hans
-
Erlinge, David
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
EuroIntervention
- Av lärosätet
-
Örebro universitet
-
Lunds universitet
-
Karolinska Institutet